The long-term cost-effectiveness of once-weekly semaglutide 1 mg vs. dulaglutide 3 mg and 4.5 mg in the UK

AIMS: Once-weekly semaglutide and dulaglutide represent two highly efficacious treatment options for type 2 diabetes. A recent indirect treatment comparison (ITC) has associated semaglutide 1 mg with similar and greater improvements in glycated haemoglobin (HbA1c) and body weight, respectively, vs....

Descripción completa

Detalles Bibliográficos
Autores principales: Viljoen, Adie, Chubb, Barrie, Malkin, Samuel J. P., Berry, Sasha, Hunt, Barnaby, Bain, Stephen C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290607/
https://www.ncbi.nlm.nih.gov/pubmed/36114904
http://dx.doi.org/10.1007/s10198-022-01514-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10290607/
https://www.ncbi.nlm.nih.gov/pubmed/36114904
http://dx.doi.org/10.1007/s10198-022-01514-1

Ejemplares similares